Evidence map›Paper›PMID 36837661›Full record

ArticleMembranes2023

Treatment Trends and Combined Methods in Removing Pharmaceuticals and Personal Care Products from Wastewater-A Review.

Paripurnanda Loganathan, Saravanamuthu Vigneswaran, Jaya Kandasamy, Agnieszka Katarzyna Cuprys, Zakhar Maletskyi, Harsha Ratnaweera

Abstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Greywater Reuse: Contaminant Profile, Health Implications, and Sustainable Solutions.International journal of environmental research and public health · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paripurnanda LoganathanFaculty of Engineering, University of Technology Sydney (UTS), P.O. Box 123, Broadway, NSW 2007, Australia.
Saravanamuthu VigneswaranFaculty of Engineering, University of Technology Sydney (UTS), P.O. Box 123, Broadway, NSW 2007, Australia.
Jaya KandasamyFaculty of Engineering, University of Technology Sydney (UTS), P.O. Box 123, Broadway, NSW 2007, Australia.
Agnieszka Katarzyna CuprysFaculty of Sciences and Technology (RealTek), Norwegian University of Life Sciences, P.O. Box 5003, NO-1432 Ås, Norway.
Zakhar MaletskyiFaculty of Sciences and Technology (RealTek), Norwegian University of Life Sciences, P.O. Box 5003, NO-1432 Ås, Norway.ORCID 0000-0002-1356-3588
Harsha RatnaweeraFaculty of Sciences and Technology (RealTek), Norwegian University of Life Sciences, P.O. Box 5003, NO-1432 Ås, Norway.

Funding

EU ERA-NET Water JPI-2018 776692
6 · The paper itself

Abstract

When discharged into wastewater, pharmaceuticals and personal care products (PPCPs) become microorganic contaminants and are among the largest groups of emerging pollutants. Human, animal, and aquatic organisms' exposures to PPCPs have linked them to an array of carcinogenic, mutagenic, and reproductive toxicity risks. For this reason, various methods are being implemented to remove them from water bodies. This report critically reviews these methods and suggests improvements to removal strategies. Biological, physical, and chemical methods such as biological degradation, adsorption, membrane filtration, and advanced electrical and chemical oxidation are the common methods used. However, these processes were not integrated into most studies to take advantage of the different mechanisms specific to each process and are synergistic in the removal of the PPCPs that differ in their physical and chemical characteristics (charge, molecular weight, hydrophobicity, hydrogen bonding, structure). In the review articles published to date, very little information is available on the use of such integrated methods for removing PPCPs. This report attempts to fill this gap with our knowledge.

Indexed as

adsorptionadvanced oxidationbiological degradationmembrane separationpharmaceutical and personnel care products

Identifiers

PMID36837661
PMCPMC9960457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.